December 19, 2013

Bristol-Myers Squibb is selling its diabetes business to AstraZeneca for up to $4.3 billion as part of an effort to focus more on specialty drugs, the company said Thursday.

December 17, 2013

Amneal Pharmaceuticals has launched a new treatment for gastroesophageal reflux disease under a partnership with a South Korean drug maker.

December 12, 2013

A panel of experts at the Food and Drug Administration has recommended approval for an experimental biotech drug under development by Bristol-Myers Squibb and AstraZeneca for a group of rare metabolic disorders.

December 2, 2013

The Food and Drug Administration has approved a generic version of a drug for schizophrenia and bipolar disorder made by Jubilant Life Sciences, the Indian drug maker said.

December 2, 2013

Pfizer on Monday announced that a wholly-owned Polish subsidiary of Pfizer has acquired the rights to Polocard, a low-dose aspirin (acidum acetylsalicylicum), and the leading over-the-counter brand for heart attack prevention in Poland, from ZF Polpharma SA.

November 13, 2013

AstraZeneca specialty drugs division MedImmune will work with author Elizabeth Pantley to publish a new guide designed to educate parents on flu prevention.

November 4, 2013

Procter & Gamble on Monday announced that celebrity chef and nutritionist Chef LaLa, and medical expert Jorge Rodriguez, will share health and nutrition tips to help families reduce the chances of heartburn as part of a brand initiative supporting Prilosec OTC.

October 17, 2013

Nearly two dozen women with heart disease will educate their communities about heart disease in women.

October 15, 2013

AstraZeneca has acquired a British developer of biotech drugs for treating cancer, AstraZeneca said Tuesday.

October 7, 2013

Safeway on Monday announced that both traditional and high-dose influenza vaccines are available nationwide. In addition, those who get a flu vaccine will receive a 10%-off coupon.

September 10, 2013

Generic drugs have been on a roll with their share of total prescriptions dispensed in the country seeming to increase on a nearly constant basis. But it appears the peak is coming soon.

September 10, 2013

What a difference a year will make. While sales of antacid tablets were down 1.3% to $2 billion for the 52 weeks ended July 14 across total U.S. multi-outlets, according to IRI, the entire category ought to have made a significant resurgence by this time next year.

August 29, 2013

NEW YORK — New Albertsons Inc. banners Shaw’s and Star Market, Acme and Jewel-Osco have announced the availability of flu shots at their pharmacies.

Specially trained pharmacists are available to administer the traditional flu vaccine, needle-free FluMist nasal spray and Fluzone Intradermal, as well as Fluzone HD for patients ages 65 years and older during regular pharmacy hours with no appointment necessary.

August 27, 2013

AstraZeneca has bought Maryland-based biotech company Amplimmune, the drug maker said.

August 26, 2013

Walgreens announced that this year's flu shots are now available at all Walgreens pharmacies, Healthcare Clinics at select Walgreens and Duane Reade pharmacies in New York.

August 12, 2013

This year, generic drugs account for 83% of all drugs dispensed in the United States, and that figure is set to get even larger over the next few years. That was among the takeaways from IMS Health VP industry relations Doug Long’s presentation Sunday morning.

August 8, 2013

Despite significant challenges coming from private label, Procter & Gamble is still attempting to innovate the No. 1 brand in all of digestives — Prilosec OTC.

July 16, 2013

Walgreens on Tuesday named Mark Lelinski as its new corporate VP, market access. Lelinski will be responsible for contracting and pricing strategies; the integration efforts across Walgreens pharmacy, health and wellness division; overseeing sales and account management; and managing the continued evolution of the company’s managed market strategies.

July 9, 2013

Mylan has received tentative approval for a generic version of a cholesterol drug made by AstraZeneca, according to Food and Drug Administration records.

June 10, 2013

Anglo-Swedish drug maker AstraZeneca will pay up to $1.15 billion for a U.S. developer of drugs for respiratory diseases, AstraZeneca said Monday.

June 7, 2013

Actavis is hoping to become the first to market generic versions of a contraceptive and a sedative, the drug maker said.

June 5, 2013

South Korean drug maker Hanmi Pharmaceutical Co. and U.S. partner Amneal Pharmaceuticals have made an agreement in federal court concerning a generic heartburn drug.

May 30, 2013

There can't be too many tried-and-true, immediate-action calcium carbonate formulations among heartburn remedies, no matter how many proton-pump inhibitors dot that shelf's landscape. At least that's what Bayer Consumer is counting on with its line extension of Alka Seltzer Fruit Chews.

May 28, 2013

Anglo-Swedish drug maker AstraZeneca will buy Omthera Pharmaceuticals for $323 million, the two companies said.